Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.

Dentali F, Marchesi C, Giorgi Pierfranceschi M, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W.

Thromb Haemost. 2011 Sep;106(3):429-38. doi: 10.1160/TH11-01-0052. Epub 2011 Jul 28.

PMID:
21800002
2.

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

Circulation. 2013 Sep 10;128(11):1234-43. doi: 10.1161/CIRCULATIONAHA.113.002283. Epub 2013 Aug 9.

3.

Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.

Voils SA, Holder MC, Premraj S, Catlin JR, Allen BR.

Thromb Res. 2015 Sep;136(3):595-8. doi: 10.1016/j.thromres.2015.07.023. Epub 2015 Jul 26.

PMID:
26233569
4.

Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Ghadimi K, Levy JH, Welsby IJ.

Anesth Analg. 2016 May;122(5):1287-300. doi: 10.1213/ANE.0000000000001188. Review.

5.

Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal.

Dentali F, Imberti D, Tamburini Permunian E, Croci E, Ageno W.

Thromb Haemost. 2014 Sep 2;112(3):621-3. doi: 10.1160/TH13-10-0851. Epub 2014 Jun 26. No abstract available.

PMID:
24965568
6.

Perioperative use of prothrombin complex concentrates.

Colomina MJ, Díez Lobo A, Garutti I, Gómez-Luque A, Llau JV, Pita E.

Minerva Anestesiol. 2012 Mar;78(3):358-68. Review.

7.

An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.

Altorjay Á, Szabó É, Boda Z, Kramer L, Ngo LY, Engl W, Firth CL, Ahlstrom ER, Gelmont DM, Pabinger I.

Thromb Res. 2015 Mar;135(3):485-91. doi: 10.1016/j.thromres.2014.12.026. Epub 2015 Jan 2.

PMID:
25613927
8.

Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting.

Joseph R, Burner J, Yates S, Strickland A, Tharpe W, Sarode R.

Transfusion. 2016 Apr;56(4):799-807. doi: 10.1111/trf.13406. Epub 2015 Nov 20.

PMID:
26589481
9.

Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients.

Johansen M, Wikkelsø A, Lunde J, Wetterslev J, Afshari A.

Cochrane Database Syst Rev. 2015 Jul 7;(7):CD010555. doi: 10.1002/14651858.CD010555.pub2. Review.

PMID:
26151108
10.

Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.

Leissinger CA, Blatt PM, Hoots WK, Ewenstein B.

Am J Hematol. 2008 Feb;83(2):137-43. Review.

11.

Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.

Cabral KP, Fraser GL, Duprey J, Gibbons BA, Hayes T, Florman JE, Seder DB.

Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24.

PMID:
22835715
12.

Reversal of warfarin anticoagulation for urgent surgical procedures.

Curtis R, Schweitzer A, van Vlymen J.

Can J Anaesth. 2015 Jun;62(6):634-49. doi: 10.1007/s12630-015-0366-3. Epub 2015 Apr 7.

PMID:
25846343
13.

Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.

Cruz JL, Moss MC, Chen SL, Hansen KM, Amerine LB.

Blood Coagul Fibrinolysis. 2015 Jun;26(4):378-82. doi: 10.1097/MBC.0000000000000259.

PMID:
25688457
14.

New strategies for effective treatment of vitamin K antagonist-associated bleeding.

Yates SG, Sarode R.

J Thromb Haemost. 2015 Jun;13 Suppl 1:S180-6. doi: 10.1111/jth.12970. Review.

15.

Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding.

Imberti D, Magnacavallo A, Dentali F, Condoleo E, Gallerani M, Benedetti R, Ageno W.

J Thromb Thrombolysis. 2013 Jul;36(1):102-8. doi: 10.1007/s11239-012-0817-4.

PMID:
23054464
16.

Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.

Majeed A, Meijer K, Larrazabal R, Arnberg F, Luijckx GJ, Roberts RS, Schulman S.

Thromb Haemost. 2014 Feb;111(2):233-9. doi: 10.1160/TH13-07-0536. Epub 2013 Oct 24.

PMID:
24154891
17.

Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.

Sarode R.

Clin Lab Med. 2014 Sep;34(3):613-21. doi: 10.1016/j.cll.2014.06.002. Epub 2014 Jul 23. Review.

PMID:
25168946
18.

Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.

Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci PM.

J Thromb Haemost. 2014 Sep;12(9):1480-7. doi: 10.1111/jth.12647. Epub 2014 Jul 24. Review.

19.

Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.

Bloomfield HE, Krause A, Greer N, Taylor BC, MacDonald R, Rutks I, Reddy P, Wilt TJ.

Ann Intern Med. 2011 Apr 5;154(7):472-82. doi: 10.7326/0003-4819-154-7-201104050-00005.

PMID:
21464349
20.

Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review.

Lin DM, Murphy LS, Tran MH.

Transfus Med Rev. 2013 Apr;27(2):91-104. doi: 10.1016/j.tmrv.2013.01.002. Epub 2013 Feb 23. Review.

Supplemental Content

Support Center